{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:24:34Z","timestamp":1787509474091,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003761","name":"Universitair Medisch Centrum Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM050009"],"award-info":[{"award-number":["GM050009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL155064"],"award-info":[{"award-number":["HL155064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR075777"],"award-info":[{"award-number":["R01AR075777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jid.2021.12.036","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T21:43:46Z","timestamp":1643147026000},"page":"2159-2172.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23\/IL-17 Pathways"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-2590","authenticated-orcid":false,"given":"Unnikrishnan M.","family":"Chandrasekharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9469-0986","authenticated-orcid":false,"given":"Raminderjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-1328","authenticated-orcid":false,"given":"Jennifer E.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-3508","authenticated-orcid":false,"given":"Chad","family":"Braley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-2353","authenticated-orcid":false,"given":"Vandana","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-190X","authenticated-orcid":false,"given":"MacKenzie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-3557","authenticated-orcid":false,"given":"Nicholas","family":"de Windt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5627-2350","authenticated-orcid":false,"given":"Jason","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-8789","authenticated-orcid":false,"given":"Ritika","family":"Jaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-8869","authenticated-orcid":false,"given":"Defne","family":"Bayik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5113-543X","authenticated-orcid":false,"given":"Rachel G.","family":"Scheraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-8427","authenticated-orcid":false,"given":"Anthony P.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-0999","authenticated-orcid":false,"given":"Paul E.","family":"DiCorleto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-4205","authenticated-orcid":false,"given":"M. Elaine","family":"Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.12.036_bib1","first-page":"1720827","article-title":"Regulatory T cells: molecular actions on effector cells in immune regulation","volume":"2016","author":"Arce-Sillas","year":"2016","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jid.2021.12.036_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jid.2021.12.036_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: keratinocytes or immune cells - which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2021.12.036_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A\u00a0metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.12.036_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation [published correction appears in Immunity 2011;35:649]","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.12.036_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/039463200902200411","article-title":"TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept","volume":"22","author":"Caldarola","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jid.2021.12.036_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09546634.2014.883059","article-title":"Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis","volume":"26","author":"Cao","year":"2015","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jid.2021.12.036_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/1521-4141(200002)30:2<652::AID-IMMU652>3.0.CO;2-L","article-title":"A\u00a0crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes","volume":"30","author":"Chan","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1182\/blood-2006-05-020875","article-title":"Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in\u00a0vivo","volume":"109","author":"Chandrasekharan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.12.036_bib11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.12.036_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/JLB.2MA0121-082R","article-title":"Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis","volume":"110","author":"Chen","year":"2021","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2021.12.036_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib14","first-page":"4","article-title":"TNF-alpha inhibitors in dermatology","volume":"12","author":"Cordoro","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jid.2021.12.036_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00296-016-3436-0","article-title":"Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies","volume":"36","author":"Elyoussfi","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jid.2021.12.036_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2021.12.036_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2013.00478","article-title":"TNF receptor 2 and disease: autoimmunity and regenerative medicine","volume":"4","author":"Faustman","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/ard.2005.045062","article-title":"SCQM physicians. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis","volume":"65","author":"Finckh","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.12.036_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jid.2021.12.036_bib20","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib21","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.180.5.3057","article-title":"Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response","volume":"180","author":"Fukunaga","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2016.13512","article-title":"Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial","volume":"316","author":"Gottenberg","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2021.12.036_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.106.647255","article-title":"Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization","volume":"115","author":"Goukassian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jid.2021.12.036_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions [published correction appears in Autoimmun Rev 2015;14:845\u20126]","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2021.12.036_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.12.036_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000028116","article-title":"Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity","volume":"68","author":"Jacobs","year":"2000","journal-title":"Pathobiology"},{"key":"10.1016\/j.jid.2021.12.036_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI45005","article-title":"Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis","volume":"124","author":"Keeton","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.12.036_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A\u00a0novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.12.036_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","article-title":"Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor","volume":"94","author":"Kristensen","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.12.036_bib32","doi-asserted-by":"crossref","first-page":"a028522","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications","volume":"10","author":"Monin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jid.2021.12.036_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"Supp.l 1","key":"10.1016\/j.jid.2021.12.036_bib34","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2021.12.036_bib35","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1128\/MCB.22.21.7512-7523.2002","article-title":"Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis","volume":"22","author":"Pan","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2021.12.036_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.12.036_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-018-0820-6","article-title":"Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2021.12.036_bib38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation","volume":"160","author":"Peschon","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.12.036_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jid.2021.12.036_bib41","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.4049\/jimmunol.157.11.5022","article-title":"Corynebacterium parvum- and Mycobacterium bovis bacillus calmette-guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI","volume":"157","author":"Senaldi","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.181.2.607","article-title":"Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in\u00a0vivo role for p75","volume":"181","author":"Sheehan","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.12.036_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jdermsci.2014.11.008","article-title":"TNF inhibitors directly target Th17 cells via attenuation of autonomous TNF\/TNFR2 signalling in psoriasis","volume":"77","author":"Shiga","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2021.12.036_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.23789","article-title":"Special Article: 2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jid.2021.12.036_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12170","article-title":"Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation","volume":"259","author":"Smigiel","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jid.2021.12.036_bib46","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jid.2021.12.036_bib47","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1073\/pnas.88.20.9292","article-title":"The two different receptors for tumor necrosis factor mediate distinct cellular responses","volume":"88","author":"Tartaglia","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.12.036_bib48","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1002\/j.1460-2075.1996.tb01007.x","article-title":"RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas\/APO-1-initiated apoptosis","volume":"15","author":"Ting","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2021.12.036_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1172\/JCI116589","article-title":"The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation","volume":"92","author":"Trefzer","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.12.036_bib50","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1128\/iai.65.5.1892-1898.1997","article-title":"Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis","volume":"65","author":"Tsuji","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jid.2021.12.036_bib51","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0962-8924(00)89088-1","article-title":"Two tumour necrosis factor receptors: structure and function","volume":"5","author":"Vandenabeele","year":"1995","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jid.2021.12.036_bib53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/hep.28551","article-title":"Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice","volume":"64","author":"Wroblewski","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jid.2021.12.036_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1546-0096-12-45","article-title":"Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-\u03b1 reagents","volume":"12","author":"Yasui","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jid.2021.12.036_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2018.00583","article-title":"The significance of tumor necrosis factor receptor type II in CD8+ regulatory T cells and CD8+ effector T cells","volume":"9","author":"Ye","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.12.036_bib56","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses [published correction appears in J Exp Med 2008;205:1941]","volume":"204","author":"Zaba","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.12.036_bib57","doi-asserted-by":"crossref","first-page":"63799","DOI":"10.18632\/oncotarget.19124","article-title":"Transmembrane TNF-\u03b1 promotes activation-induced cell death by forward and reverse signaling","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.12.036_bib58","doi-asserted-by":"crossref","first-page":"51267","DOI":"10.1074\/jbc.M310678200","article-title":"Etk\/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway","volume":"278","author":"Zhang","year":"2003","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:28:11Z","timestamp":1758302891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0022202X22000185"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.12.036","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23\/IL-17 Pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}